The largest database of trusted experimental protocols

Obatoclax

Manufactured by Merck Group
Sourced in United States

Obatoclax is a laboratory research product manufactured by Merck Group. It is an organic compound used in scientific research applications.

Automatically generated - may contain errors

2 protocols using obatoclax

1

Pre-miR-21 Folding and Compound Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unmodified, desalted, and HPLC purified pre-miR-21 was purchased
from Eurofins Scientific (Louisville, KY, USA). RNA was folded via
resuspending with buffer (10 mM Tris-HCl pH 7.5 with 20 mM NaCl), and heated
to 95°C for 90 sec, and allowed to cool to room temperature
overnight. Folded RNA was aliquoted and stored in −20°C until
assayed. The following sequence of pre-miR-21 was purchased:
5’-UGUCGGGUAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGAUGGGCU
GUCUGACA-3’
Butylcycloheptyl prodiginine (bPGN) was supplied by Developmental
Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis in
the National Cancer Institute (NCI). Plates for high-throughput screens were
provided by NCI, Molecular Targets Program (MTP). Compounds such as 5-FU,
obatoclax, prodigiosin, navitoclax, spermidine, methoctramine,
hexachlotophene, and regorafenib were purchased from Sigma Aldrich or
selleckchem.com.
+ Open protocol
+ Expand
2

Quantifying Cell Proliferation using BrdU Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BrdU incorporation assay was performed as described previously (Lee and Lee, 2014 (link)). In brief, after 24 h of seeding with 2 × 104 cells/ well in 96-well plates, the cells were treated with obatoclax or PD98059 (Sigma, USA). Cell proliferation was assayed using the BrdU incorporation assay kit (Cell Signaling Technology) according to the manufacturer’s instructions. BrdU was added 12 h before culture termination. At the end of culture, cells were fixed with fixing solution for 30 min at RT, rinsed twice with PBS, incubated with monoclonal anti-BrdU antibody for 1 h, followed by anti-mouse secondary antibody for 30 min. After the final wash, the substrate was added to the wells and then the stop solution was administered. The proportion of total cells incorporating BrdU into the nucleus was determined by reading the absorbance on a microplate reader (Bio-Rad) at 450 nm to calculate cell viability.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!